INTERNATIONAL PATENT: ASTRAZENECA UK LIMITED, DAIICHI SANKYO COMPANY, LIMITED FILES APPLICATION FOR "COMBINATION OF ANTIBODY-DRUG CONJUGATE AND BLOOD BRAIN BARRIER-PENETRANT PARP1 SELECTIVE INHIBITOR"

GENEVA, June 16 -- ASTRAZENECA UK LIMITED (1 Francis Crick AvenueCambridge Biomedical CampusCambridge CB2 0AA), DAIICHI SANKYO COMPANY, LIMITED (3-5-1, Nihonbashi HonchoChuo-kuTokyo, 103-8426) filed a patent application (PCT/IB2024/062174) for "COMBINATION OF ANTIBODY-DRUG CONJUGATE AND BLOOD BRAIN BARRIER-PENETRANT PARP1 SELECTIVE INHIBITOR" on Dec 04, 2024. With publication no. WO/2025/120513, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COSULICH, Sabina (c/o AstraZeneca UK Limited1 Francis Crick AvenueCambridge Biom...